98 related articles for article (PubMed ID: 7030601)
1. Pseudomonas in cystic fibrosis sylph or sycophant?
Fick RB
Clin Chest Med; 1981 Jan; 2(1):91-102. PubMed ID: 7030601
[No Abstract] [Full Text] [Related]
2. Microbial lung infections: new therapeutic strategies.
Döring G
Pathol Biol (Paris); 1991 Jun; 39(6):587-91. PubMed ID: 1923589
[No Abstract] [Full Text] [Related]
3. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
Ramsey DM; Wozniak DJ
Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
[TBL] [Abstract][Full Text] [Related]
4. The management of cystic fibrosis. Observations on gentamycin when used with other antibiotics in pulmonary infections associated with cystic fibrosis.
Shwachman H; Khaw KT; Kowalski SM
Clin Pediatr (Phila); 1975 Dec; 14(12):1115-8. PubMed ID: 1192683
[No Abstract] [Full Text] [Related]
5. [Bronchial mucins and infection in cystic fibrosis].
Lamblin G; Ramphal R
Pathol Biol (Paris); 1991 Jun; 39(6):592-7. PubMed ID: 1923590
[No Abstract] [Full Text] [Related]
6. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
Madsen V; Lind A; Rasmussen M; Coulthard K
J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response.
Pedersen SS; Kharazmi A; Espersen F; Høiby N
Infect Immun; 1990 Oct; 58(10):3363-8. PubMed ID: 2401567
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa infection in cystic fibrosis: biosynthesis of alginate as a virulence factor.
Roychoudhury S; Zielinski NA; DeVault JD; Kato J; Shinabarger DL; May TB; Maharaj R; Kimbara K; Misra TK; Chakrabarty AM
Antibiot Chemother (1971); 1991; 44():63-7. PubMed ID: 1801646
[No Abstract] [Full Text] [Related]
9. Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
Mukhopadhyay S; Singh M; Ogston S; Ryan G; Smyth R
J R Soc Med; 1998; 91 Suppl 34(Suppl 34):25-9. PubMed ID: 9709385
[No Abstract] [Full Text] [Related]
10. Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection.
Høiby N; Giwercman B; Jensen ET; Pedersen SS; Koch C; Kharazmi A
Adv Pharmacol; 1994; 30():53-84. PubMed ID: 7833297
[No Abstract] [Full Text] [Related]
11. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
Michel BC
Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
[No Abstract] [Full Text] [Related]
12. Pulmonary infection in cystic fibrosis--still a sticky problem.
Lancet; 1986 Dec; 2(8520):1372-3. PubMed ID: 2878232
[No Abstract] [Full Text] [Related]
13. The use of steroids in cystic fibrosis.
Auerbach HS
Antibiot Chemother (1971); 1989; 42():254-6. PubMed ID: 2688546
[No Abstract] [Full Text] [Related]
14. Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
Douchain F; Lebas L; Houdas S; Chivet C; Bakhache P; Pautard JC
Acta Univ Carol Med (Praha); 1990; 36(1-4):37-9. PubMed ID: 2130714
[No Abstract] [Full Text] [Related]
15. Chinks in the armor of the airway: Pseudomonas infection in the cystic fibrosis lung.
Ferkol TW; Look DC
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):11-3. PubMed ID: 11472969
[No Abstract] [Full Text] [Related]
16. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM
J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290
[TBL] [Abstract][Full Text] [Related]
17. Alginate in infection.
Pedersen SS; Høiby N; Espersen F; Kharazmi A
Antibiot Chemother (1971); 1991; 44():68-79. PubMed ID: 1801647
[No Abstract] [Full Text] [Related]
18. Update on treatment of pulmonary exacerbations in cystic fibrosis.
Smyth A
Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
[TBL] [Abstract][Full Text] [Related]
19. Inhaled tobramycin (TOBI).
Bonsignore CL
Pediatr Nurs; 1998; 24(3):258-9. PubMed ID: 9987427
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis: the welcome problems of success/Part 1.
Guidoitti TL; Di Sant' Agnese Pa
Md State Med J; 1981 Mar; 30(3):68, 71-3. PubMed ID: 7218891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
